Partner Headlines - BIIB

  1. Benzinga's Volume Movers

    Benzinga
  2. Biogen, AGTC find genetic link

    IBD
  3. Mid-Afternoon Market Update: International Speedway Slips On ...

    Benzinga
  4. Mid-Day Market Update: US Stocks Down; Xoom Shares Jump On Acquisition ...

    Benzinga
  5. Thursday's Mid-Day Movers: Real Good Solar, Xoom, ConforMIS, ...

    Benzinga
  6. Biogen, AGTC Link Up To Develop Gene Therapy

    IBD
  7. Mid-Morning Market Update: Markets Edge Higher; Centene To Acquire ...

    Benzinga
  8. Benzinga's Volume Movers

    Benzinga
  9. Morning Market Gainers

    Benzinga
  10. Benzinga's Top #PreMarket Gainers

    Benzinga
  11. Juno, Celgene Lead 5 Top Biotechs Nearing Buy Point

    IBD
  12. Roche 'High Efficacy' MS Drug Succeeds In Trials

    IBD
  13. Perrigo Going Up With Or Without Mylan, Says BMO

    IBD
  14. Biogen Phase 3 Study Of Aducanumab

    Benzinga
  15. Health Care Stocks Power S&P 500 To Q1 Earnings Beat

    IBD
  16. Stocks Stay In The Red, But IPOs FitBit, Fogo Score Big Gains

    IBD
  17. Fitbit Keeps Up Pace As Stocks Remain Near Session Highs

    IBD
  18. Big Biotech Stocks See Declining Short Interest

    Benzinga
  19. Isis rises on drug's results

    IBD
  20. Isis, Biogen Rare-Disease Drug Aids Infant Survival

    IBD
  21. Meet 8 Hot Med Stocks Among IBD's Big Cap Leaders

    IBD
  22. Health Care Mutual Funds Top In May: Close Look At Two Winners

    IBD
  23. Investment Strategies for the Bullish Biotech Sector

    GuruFocus
  24. Apple, SunEdison and Biogen: Hellman, Jordan Management's Top ...

    GuruFocus
  25. PRIMECAP Sells Portions of Its Top Two Stakes

    GuruFocus
  26. Move Over Chip Stocks: Here Are 5 Top Biotechs

    IBD
  27. 5 NASDAQ Healthcare Stocks With The Highest EPS

    Benzinga
  28. Move Aside, Chip Stocks, Biotechs Are Leaders Too

    IBD
  29. China ETFs Power Ahead In 2015; Gold, Silver Get Shine Back

    IBD
  30. 3 Biotech Stocks See Growing Short Interest

    Benzinga
  31. Q1 Earnings Drive Industry Group Winners And Losers

    IBD
  32. SolarEdge Shares, Up 15%, Lead Techs' Late Rise

    IBD
  33. BIOGEN

    IBD
  34. Frothy China Or No, World Mutual Funds Topped In April

    IBD
  35. Isis Pharma Up As Bayer Licenses Thrombosis Drug

    IBD
  36. Biogen Making A Breakthrough In Treating Alzheimer's

    GuruFocus
  37. Growth Names Pressured As IBD 50 Slumps 4% For Week

    IBD
  38. Vanguard Healthcare Fund Adds Four New Positions

    GuruFocus
  39. Top-Rated Biotech Unravels Base-Building Effort

    IBD
  40. Biogen or Bluebird: Which Will Lead in SCD?

    GuruFocus
  41. Indexes Lower, Near Session Lows As Fed Announcement Nears

    IBD
  42. Biogen Continues To Decline After Friday's Rout

    Benzinga
  43. Biogen Misses On Tecfidera

    IBD
  44. With Market Back In Uptrend, IBD 50 Growth Names Thrive

    IBD
  45. Stocks Finish Solid Week; Akorn Restates 2014 Revenue

    IBD
  46. Biogen Shares Not Too Healthy After Q1 Miss

    Benzinga
  47. Chips Fall, But Nasdaq Holds Up; Avago Slices 50-Day Line

    IBD
  48. Stocks Firm Up As Amazon, Starbucks Gap To New Highs

    IBD
  49. Nasdaq Takes Lead In Mixed Open; Microsoft Surges, Biogen Dives

    IBD
  50. Biogen Q1 Misses Estimates As Tecfidera Stalls

    IBD
  51. Biogen Misses Q1 Estimates, Shares Slide

    Benzinga
  52. Must Watch Stocks for April 24, 2015

    Benzinga
  53. Earnings Scheduled For April 24, 2015

    Benzinga
  54. Biogen Earnings Preview: What To Look For

    IBD
  55. Making Money With Charles Payne: 04/23/15

    FoxBusiness
  56. Nasdaq Hits Record Close; Google, Amazon Rise After Hours

    IBD
  57. Analysts Provide Update for Biogen, PTC Therapeutics, GW Pharma, ...

    GuruFocus
  58. Kyle Bass Challenges Biogen Fumaderm Patent

    Benzinga
  59. US Stock Futures Rise Ahead Of Earnings

    Benzinga
  60. PLEGRIDY 3-Year Data Presented at AAN Annual Meeting Support ...

    Benzinga
  61. CAR-T Therapy Stocks Hit Hard Following AACR Data

    Benzinga
  62. 5 Biotech Earnings Under The Microscope This Week

    Benzinga
  63. Meet 4 IBD 50 Companies Reporting Earnings This Week

    IBD
  64. How To Invest In ETFs: Tips To Trade Top Market Trends

    IBD
  65. 5 Top IBD 50 Stocks Stay On Course Despite Sell-Off

    IBD
  66. It's A Big Weekend For Biotech

    Benzinga
  67. Mr. Valuation disagrees with Henry Blodget: 'It's a Market of ...

    GuruFocus
  68. Receptos MS Drug Succeeds Against Ulcerative Colitis

    IBD
  69. New drug trial results positive

    IBD
  70. Pfizer, Biogen, AbbVie Get Good Drug-Trial News

    IBD
  71. Stock Futures Grapple Higher; Biogen, Akorn Lead IBD 50 List

    IBD
  72. GoPro, Avon and Intel Highlight Tuesday's After-Hours Movers

    Benzinga
  73. BIOGEN IDEC

    IBD
  74. Biogen Reports New Anti-LINGO-1 Phase 2 Acute Optic Neuritis ...

    Benzinga
  75. Top Funds Buying Rackspace, Allergan ogen Idec, Apple

    IBD
  76. Big Cap 20 Reflecting Market Leadership

    IBD
  77. How To Invest: Avoid Bases Of Low-Priced Stocks

    IBD
  78. Medivation Tops Q4 Views On Strong Xtandi Results

    IBD
  79. The Catalysts Biogen Idec Investors Should Watch

    Benzinga
  80. United Therapeutics Blood Pressure Drug Spurs Q4 Beat

    IBD
  81. Drugmaker Mylan Takes Part In Pharma Feeding Frenzy

    IBD
  82. Pharma M&A: Bristol-Myers, Valeant Make Deals

    IBD
  83. Evercore ISI Technical Analysis: The 'Single Best Idea'

    Benzinga
  84. February Pick Of Biotech Stocks

    GuruFocus
  85. Stanley Druckenmiller's Recent Trades

    GuruFocus
  86. 8 Strong Recommendations for 2015

    GuruFocus
  87. Stocks End Mixed: Molina Healthcare Rises Again

    IBD
  88. Stocks Open Mixed, Techs Climb; Rite Aid, Akamai, AmTrust Jump

    IBD
  89. Regeneron Q4 Sales, 2015 Outlook Upbeat On Eylea

    IBD
  90. No Deceleration Here: 14 Stocks With Accelerating Profits

    IBD
  91. Nuveen's Bob Doll Runs Several Top Funds

    IBD
  92. Top Performing Funds Favor Leisure, Medical, REITs

    IBD
  93. iShares NASDAQ Biotech ETF Pulls Back Off All-Time Highs

    Benzinga
  94. Super Bowl Stocks: Seattle's Best Vs. Boston Strong

    IBD
  95. Many Leading Stocks Stumble But Biogen, Harman Soar

    IBD
  96. Stocks Slide Into Closing Bell; Day's Winners: Amazon, Biogen

    IBD
  97. Indexes Mired In Red; Amazon, Biogen, Visa Buck Trend

    IBD
  98. Stocks Extend Losses; Biogen Idec Gains

    IBD
  99. Stocks Open Down In Weak Trade; Biogen, Visa Soar On Q4 Results

    IBD
  100. Stocks Hitting 52-Week Highs

    Benzinga
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!